story of the week
Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Communications
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Very Low Mutation Burden Is a Feature of Inflamed Recurrent Glioblastomas Responsive to Cancer Immunotherapy
Nat Commun 2021 Jan 13;[EPub Ahead of Print], M Gromeier, MC Brown, G Zhang, X Lin, Y Chen, Z Wei, N Beaubier, H Yan, Y He, A Desjardins, JE Herndon, FS Varn, RG Verhaak, J Zhao, DP Bolognesi, AH Friedman, HS Friedman, F McSherry, AM Muscat, ES Lipp, SK Nair, M Khasraw, KB Peters, D Randazzo, JH Sampson, RE McLendon, DD Bigner, DM AshleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.